Anti-Human CD279 Recombinant Antibody(Spartalizumab)

Name: Anti-Human CD279 Recombinant Antibody(Spartalizumab)
Brand: KMD Bioscience
SKU: YR1475

YR1475

科研级 Spartalizumab, Anti-CD279 Recombinant Antibody, Research Grade Spartalizumab

DATASHEET MSDS

Product Description

Alias	科研级 Spartalizumab, Anti-CD279 Recombinant Antibody, Research Grade Spartalizumab
Catalog Number	YR1475
Molecular Name	Spartalizumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG4 Kappa
Formulation	PBS, pH7.5
Background	Spartalizumab (INN, development code PDR001) is a monoclonal antibody that is being investigated for melanoma. This drug is being developed by Novartis. As of 2018, spartalizumab is undergoing Phase III trials.
CAS Number	1935694-88-4
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	CD279[Homo sapiens]

Login